Literature DB >> 825902

The interaction between pilocarpine and hexobarbital in male rats.

G Wahlström.   

Abstract

The interaction between pilocarpine and hexobarbital was studied in male rats. Hexobarbital was infused continously. The dose needed to obtain an EEG criterion (the "silent second") was determined. The ensuing anesthesia times after these equi-anesthetic doses were also recorded. At different times prior to the hexobarbital threshold determination the rats were pretreated with 25-200 mg/kg of pilocarpine. In most experimental series pretreatment with methylatropine (2 mg/kg s.c.) was also given to reduce the effects of pilocarpine on peripheral cholinergic sites. In the dose-response study pilocarpine was given 1 h prior to the hexobarbital threshold determination. Pilocarpine in doses of 25-50 mg/kg increased the amount of hexobarbital needed to obtain the "silent second". With higher doses of pilocarpine, increases in hexobarbital thresholds were seen if no convulsion had been induced by the pilocarpine treatment. If a convulsion was recorded the dose of hexobarbital was reduced. Similar results were obtained in the time-effect studies where more convulsions tended to appear if the time between the dose of pilocarpine and the dose of hexobarbital was increased. In animals without convulsions the effect of pilocarpine on the dose of hexobarbital was counteracted by atropine (8 mg/kg i.p.). The ensuing anesthesia times were increased in the pilocarpine pretreated animals, which could be due to either the pilocarpine dose, the increased dose of hexobarbital needed to obtain the "silent second", or both. No regression between body temperature and dose of hexobarbital was found, but there was a regression with the ensuing anesthesia times. The effects of pilocarpine with an increase in hexobarbital threshold is similar to the changes seen in the threshold in the abstinence after chronic barbital treatments. More important, however, is that both increases are reduced by convulsions. Could pilocarpine be a model for the changes in the abstinence after barbital?

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825902     DOI: 10.1007/BF00427284

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS.

Authors:  A HERZ; H TESCHEMACHER; A HOFSTETTER; H KURZ
Journal:  Int J Neuropharmacol       Date:  1965-07

2.  The significance of brain acetylcholine.

Authors:  J CROSSLAND
Journal:  J Ment Sci       Date:  1953-04

3.  [Cerebral cholinoceptive systems--action of acetylcholine, physostigmine, pilocarpine and GABA].

Authors:  M MONNIER; W ROMANOWSKI
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1962-08

4.  The interaction between hexobarbital and atropine or methylatropine in male rats.

Authors:  G Wahlström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-01

5.  Hexobarbital (enhexymalum NFN) sleeping times and EEG threshold doses as measurements of tolerance to barbiturates in the rat.

Authors:  G Wahlström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1968

6.  The interaction between some anticholinesterase drugs and atropine on the pentobarbital sleeping time in the rat.

Authors:  S O Kayaalp; S Numanoğlu
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-12

7.  Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation.

Authors:  K I Yamamoto; E F Domino
Journal:  Int J Neuropharmacol       Date:  1967-09

8.  Hexobarbitone sleeping time in rats following doses with similar EEG changes.

Authors:  G Wahlström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

9.  Estimation of sensitivity to hexobarbitone (enhexymal NFN) in rats by an EEG threshold.

Authors:  G Wahlström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

10.  Tolerance to hexobarbital and supersensitivity to pilocarpine after chronic barbital treatments in the rat.

Authors:  G Wahlstrŏm; T Ekwall
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

View more
  3 in total

1.  The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.

Authors:  G Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatments in the rat.

Authors:  G Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1976-08-17       Impact factor: 4.530

Review 3.  Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines.

Authors:  A Nordberg; G Wahlström
Journal:  J Neural Transm Gen Sect       Date:  1992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.